Metraipolis › archive › dc_44c806bc75fd

Mesenchymal stem cells added to second-line therapy improve response and failure-free survival in steroid-refractory acute graft-versus-host disease after… — Europe PMC PMID:41262904

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41262904
DOI
10.3389/fonc.2025.1704963
License (as archived)
solo-consultazione
Archived
2026-11-08T19:21:12.208Z
SHA-256 of the archived text
c07359e7b450037193a7ee5d937571caa95f5852e844ce0891cf9b2c537f89f8
Stable URL of this page
https://metraipolis.com/documento/dc_44c806bc75fd

How to cite

Mesenchymal stem cells added to second-line therapy improve response and failure-free survival in steroid-refractory acute graft-versus-host disease after… — Europe PMC PMID:41262904 — Europe PMC (en), https://europepmc.org/article/MED/41262904 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_44c806bc75fd (Metraipolis archive dc_44c806bc75fd, sha256 c07359e7b450037193a7ee5d937571caa95f5852e844ce0891cf9b2c537f89f8)
BibTeX
@misc{dc44c806bc75fd,
  title = {Mesenchymal stem cells added to second-line therapy improve response and failure-free survival in steroid-refractory acute graft-versus-host disease after… — Europe PMC PMID:41262904},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41262904},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_44c806bc75fd; sha256 c07359e7b450037193a7ee5d937571caa95f5852e844ce0891cf9b2c537f89f8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41262904. Agents can read the archived copy with the MCP tool read_document.